Abstract Library

#2919 Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II Studies of Lu-Octreotate Peptide Receptor Radionuclide Therapy (LuTate PRRT) +/- Capecitabine, Temozolomide (CAPTEM) or CAPTEM Alone for Neuroendocrine Tumours (NETs

Introduction: Chemotherapy is often combined with PRTT to treat NETs of pancreatic or midgut origin (pNET/mNET) based on the principle of radiosensitization.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Pavlakis N

Authors: Pavlakis N, Ransom D, Wyld D, Sjoquist K, Asher R,

Keywords: Lutate, PRRT, chemotherapy, CAPTEM, NETs,

#1776 External Beam Radiotherapy (EBRT) in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review

Introduction: EBRT is infrequently used to treat GEPNETS.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Chan D, Thompson R, Lam M, Pavlakis N, Hallet J,

Keywords: EBRT, review,

#1366 CommNETS: Formation of an International Commonwealth Countries NET Partnership

Introduction: Neuroendocrine tumours (NETs) care is challenging in Canada, Australia and New Zealand due to small populations in large geographical space, limited drug funding, and lack of NET awareness. There is a need for collaboration to focus research and improve care and outcomes for NET patients in these nations with similar health systems.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Singh S

Authors: Singh S, Lawrence B, Chan D, Pavlakis N, Segelov E,

Keywords: research, society,

#1358 Identifying and Prioritising Gaps in Neuroendocrine Tumour Research - Results of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS)

Introduction: The newly formed CommNETS group used the robust Delphi methodology with broad stakeholder engagement to form a strategic research agenda.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Segelov E

Authors: Segelov E, Chan D, Harris-Roxas B, Lawrence B, Pavlakis N,

Keywords: research, gaps, priorities, Delphi ,

#1310 Current Trials in Neuroendocrine Tumours: A Systematic Review

Introduction: Trials in neuroendocrine tumours (NETs) have increased markedly in number over the last 10 years. Researchers do not have ready access to a summary of open trials to identify research gaps.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Chan D, Segelov E, Millican J, Singh S, Pavlakis N,

Keywords: trials, review,